Acalabrutinib

Back to search

Molecule Structure

Scientific Name

Acalabrutinib

Description of the Drug

Acalabrutinib is a Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11703

Brand Name(s)

Calquence

Company Owner(s)

Astrazeneca Uk Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tyrosine-protein kinase BTK SINGLE PROTEIN INHIBITOR CHEMBL5251

Unichem Links

SureChEMBL SCHEMBL14637368
DrugBank DB11703
PubChem 71226662
BindingDB 50175583
DrugCentral 5260
ChemicalBook CB22756514
Guide to Pharmacology 8912
rxnorm ACALABRUTINIB CALQUENCE
ChEBI 167707
ZINC ZINC000208774715